FindDrugs.org

Sprout Health Weight Loss / GLP-1 Review

Weight Loss / GLP-1 · Reviewed Sep 14, 2026

5.26/10
Sprout Health operator trust5.32/10See the full Sprout Health brand review
No commitmentFastest startCash-pay

Our verdict

Sprout Health is a cash-pay telehealth brand (Sprout Health Partners LLC, joinsprouthealth.com) selling compounded semaglutide and tirzepatide through an asynchronous, no-labs intake, with a company-asserted (but not independently verified) accreditation, and its published starting prices. It ranks last among the GLP-1 brands reviewed here, weighed down by a September 2025 FDA misbranding warning letter over 'FDA-approved' claims, a BBB F rating driven by unanswered complaints, mixed-to-negative Trustpilot sentiment, and widely reported cancellation and shipping problems. It suits price-focused shoppers comfortable with a light-touch, message-based care model who will manage the subscription closely.

Price

from $249/mo · 2 plans

Visit Sprout Health

We may earn a commission if you sign up through this link. It never affects rankings or scores. Not medical advice.

Key takeaways

  • Cash-pay telehealth (Sprout Health Partners LLC) selling compounded semaglutide and tirzepatide in ~44 states; accreditation is claimed by the company but not independently verifiable
  • Published starting prices (semaglutide ~$149-$249/mo, tirzepatide ~$199-$299/mo) with no membership or consultation fee; month-to-month
  • FDA misbranding warning letter (Sept 9, 2025) over false/misleading 'FDA-approved' claims
  • BBB F rating for failure to respond to complaints; widespread cancellation difficulty (some customers resort to chargebacks)
  • Async quiz-only screening with no required labs; shipping delays and unresponsive support are the most consistent complaints
  • Lowest-ranked GLP-1 brand in this set (5.56/10); verified Trustpilot 3.6/5 across only 115 reviews (weak signal)

What is Sprout Health Weight Loss / GLP-1?

Sprout Health is a direct-to-consumer weight-loss telehealth platform operated by Sprout Health Partners LLC, based in Encinitas, California and founded in 2023. It connects patients with licensed providers through the MD Integrations network and prescribes compounded semaglutide and tirzepatide, dispensed through partner pharmacies that it does not name publicly. The service is available in roughly 44 states (excluding Alabama, Arkansas, Mississippi, Louisiana, California, and North Dakota). The company describes itself as accredited and HIPAA-compliant, though the accreditation could not be independently verified on accreditation-registry's public directory and rests on Sprout's own statements and third-party reviews. In most states it does not require lab work or a live telehealth visit; screening is handled through an online questionnaire. Its homepage does not name specific clinicians or spell out eligibility criteria, which surface mainly through third-party sources. Sprout Health Partners LLC is the entity named in the FDA's September 9, 2025 warning letter; it should not be confused with unrelated companies sharing the Sprout Health name.

Treatment options

Prices as of Sep 14, 2026 — verify current on the brand's site.

Getting started with Sprout Health

  1. Complete the online intake questionnaire (health history, BMI, contraindication screening)
  2. Get your answers reviewed by a provider via MD Integrations, typically same/next business day, with no labs and no live visit in most states
  3. Receive a prescription if eligible; compounded medication ships from a partner pharmacy (advertised 5-7 days, often longer per complaints)
  4. Use message-based support and monthly check-ins for dose adjustments
  5. Track your monthly auto-renewal date and confirm any cancellation

Methodology scorecard

Scored on Sep 14, 2026 under methodology v6

5.26/10

Coverage: Checked against 4 recorded withdrawals. Marking matches the wording each withdrawal was recorded in, so the same claim stated differently is not marked.

Pricing & cancellation

Visit Sprout Health

All-in price

from $249/mo · 2 options

Cost structure
No long-term contract; plans auto-renew monthly.
Insurance vs. cash
Cash-pay
Deal structure
Cancellation
Month-to-month, no contract or cancellation fee on paper, but numerous complaints of being unable to cancel; some use chargebacks.
Forced subscription
Required

Pros & cons

Pros

  • LegitScript certification advertised by the company (not independently verifiable on LegitScript's directory)
  • No contracts, no membership or consultation fees; month-to-month
  • Fast prescription turnaround (same/next business day, no labs required)
  • Disclosed provider network (MD Integrations)

Cons

  • FDA warning letter (Sept 9, 2025) for false/misleading FDA-approval claims
  • BBB F rating; failure to respond to complaints
  • Widespread cancellation difficulty - customers report resorting to chargebacks
  • Shipping delays (advertised 5-7 days often 2-5 weeks per complaints)
  • Async quiz-only screening with no required labs; homepage lacks named clinicians/eligibility

Safety

Talk to a licensed clinician

Screening uses standard BMI thresholds (a BMI of 30 or above, or 27 or above with a weight-related condition) plus contraindication questions, but it is asynchronous and quiz-only, with no required lab work and, in most states, no mandatory live visit. That lighter verification is the core clinical-oversight concern. Common GLP-1 side effects reported for this drug class include nausea, vomiting, diarrhea, constipation, and injection-site reactions. Disqualifying conditions include a personal or family history of medullary thyroid cancer, multiple endocrine neoplasia syndrome type 2, a history of pancreatitis, and pregnancy. Separately, BBB complaints describe some customers receiving incorrect or incomplete medications, which is an operational quality concern rather than medical guidance. As neutral regulatory context, compounded semaglutide and tirzepatide are not individually FDA-approved products, and whether either is appropriate for a given patient is a decision for a licensed clinician — offering compounded or branded options is a lawful, common telehealth practice, not evidence of wrongdoing. Any decision about whether a GLP-1 is appropriate should be made with a licensed clinician; this is information for comparing providers, not medical advice.

Common side effects

  • Nausea
  • Vomiting
  • Diarrhea
  • Constipation
  • Injection-site reactions

Who should not take it

  • Personal or family history of medullary thyroid carcinoma (MTC)
  • Multiple endocrine neoplasia syndrome type 2 (MEN2)
  • History of pancreatitis
  • Pregnancy

The bottom line

Sprout Health delivers compounded semaglutide and tirzepatide at competitive, starting-price cash prices with no membership fee, and it is a legitimate, real operating entity (it advertises accreditation, though FindDrugs could not confirm that on accreditation-registry's public directory). But it earns the lowest GLP-1 score here because the honest negatives are the story: a September 2025 FDA warning letter over 'FDA-approved' marketing claims, a BBB F rating for unanswered complaints, mixed low-volume Trustpilot sentiment, an async no-labs screening model, and persistent cancellation, shipping, and support problems. Price-sensitive patients who value the dose-lock and will manage the subscription may find it workable; anyone prioritizing responsive support, hands-on clinical oversight, or a clean service record should look at higher-ranked alternatives.

Visit Sprout Health

We may earn a commission if you sign up through this link. It never affects rankings or scores. Not medical advice.

See how Sprout Health ranks among GLP-1 providers

What changed & why

This brand's own history — every re-review and methodology recompute, logged. Rankings change when the evidence or the rules change, never for payment. See the site-wide methodology ledger for version history.

  1. Sep 14, 2026Methodologymethodology v65.245.26

    We changed how this score is calculated, and Weight Management / GLP-1 score moved from 5.24 to 5.26. 1 of the factors behind it moved. How we score.

    1 factor withdrawn — assessed coverage fell 13 → 12. Part of any score movement here reflects evidence we retracted, not a change in the brand.

  2. Aug 11, 2026Claim withdrawn5.575.24

    Weight Management / GLP-1 score moved from 5.56 to 5.24 after we withdrew 2 claims we could not source to a primary record. 4 of the factors behind it moved.

    2 factors withdrawn — assessed coverage fell 15 → 13. Part of any score movement here reflects evidence we retracted, not a change in the brand.

  3. Jul 24, 2026Re-review8.305.57

    Weight Management / GLP-1 score moved from 8.30 to 5.56 after a fresh review of the evidence. 15 of the factors behind it moved.

    Whether this score rests on more or less evidence than the previous one is not recorded — the earlier score did not store how many factors it assessed.

Frequently asked questions

Is Sprout Health legit?

Sprout Health (Sprout Health Partners LLC) is a real telehealth brand with a licensed provider network; we could not find a partner pharmacy named on its own site, so we have not established that it names none publicly. It advertises accreditation, but FindDrugs could not independently confirm that on accreditation-registry's public directory, so treat it as a company claim rather than a verified accreditation. It also received an FDA warning letter in September 2025 over false or misleading 'FDA-approved' claims, and it holds a BBB F rating for failing to respond to customer complaints, so weigh those factors before enrolling.

How much does Sprout Health cost?

Compounded semaglutide is quoted from about $149 to $249 per month and compounded tirzepatide from about $199 to $299 per month, with no separate membership or consultation fee. Pricing is starting-price, so your rate stays fixed as you titrate up. Quoted figures vary by source, and plans auto-renew monthly.

Can I cancel Sprout Health easily?

On paper Sprout is month-to-month with no cancellation fee, but cancellation is a common complaint. You can get a full refund before the pharmacy ships, but none once the prescription is transmitted, and some customers report being unable to cancel and having to dispute charges through their credit card company. Track your renewal date and confirm cancellation in writing.

Does Sprout Health require lab work or a doctor visit?

In most states, no. Screening is an asynchronous online questionnaire, and Sprout states it does not require lab work and that most people will not need a live telehealth appointment. That makes for fast prescriptions but lighter clinical oversight than services requiring labs or a video visit.

Work at Sprout Health?

If something here is wrong or out of date, send us a correction request. We read every one and decide what changes — it does not edit the review or move a score.

Sources & how we researched this

Scored on 12 of 14 factors · 5 sources cited

Regulatory

Reviews

Other

What we couldn't verify

  • Two unrelated 'Sprout Health' entities exist; this review confirms the DTC compounded-GLP-1 brand is Sprout Health Partners LLC at joinsprouthealth.com (Encinitas, CA), named in the FDA's Sept 9, 2025 warning letter.
  • Pharmacy 503A vs 503B status reported differently across sources and not confirmed on Sprout's own site.
  • Advertised compounded pricing varies materially by source ($149 vs $249 semaglutide).
  • FDA warning letter page returned 404 on direct fetch; corroborated via FDA search listing and Pharma Now.
  • Trustpilot now verified 3.6/115 (rendered fetch 2026-07-24); low volume (115 reviews) keeps it a weak signal.
  • Withdrawn — Sprout Health's named partner pharmacies (Foothills Pharmacy, Promise Pharmacy). Sprout Health's named partner pharmacies (Foothills Pharmacy, Promise Pharmacy) are WITHDRAWN. The source is described in our own payload as "syndicated GlobeNewswire/Yahoo Finance PR coverage" — a wire release, which the 2026-08-06 ruling rejects — and joinsprouthealth.com names no pharmacy (fetched 2026-08-10).
  • Withdrawn — Sprout Health's "dose-locked pricing" claim. Sprout Health's "dose-locked pricing" claim is WITHDRAWN — same syndicated release; joinsprouthealth.com states starting prices ("Starting at $149 month" semaglutide, "Starting at $199 month" tirzepatide) with no dose-lock guarantee (fetched 2026-08-10).
  • Withdrawn — third-party assertion that Sprout Health is "HIPAA compliant; LegitScript certified". The third-party assertion that Sprout Health is "HIPAA compliant; LegitScript certified" is WITHDRAWN. It directly CONTRADICTS this payload's own legitimacy finding, which records that LegitScript's checker returned no retrievable certification record for joinsprouthealth.com. Two citations in one payload cannot say opposite things; the one that says "unverifiable" is the one that did the checking.
  • Withdrawn — Sprout Health's momentum signal. Sprout Health's momentum signal is WITHDRAWN as evidence. The citation's own quote described it: "Syndicated GlobeNewswire/Yahoo Finance PR coverage of Sprout Health GLP-1 program in 2026." A brand's own press release circulating is not evidence that the brand is growing.
  • data-privacy-security: re-encoded as a RETRIEVAL GAP (excluded, re-normalized out of the score) rather than brand opacity. Sprout's own footer carries a HIPAA notice link and a LegitScript badge — it DOES disclose in kind. What failed is verification: LegitScript's checker is reCAPTCHA-gated and returned no retrievable record. Retrieval failure, not opacity.
  • glp1-titration-autonomy: re-encoded as a RETRIEVAL GAP (excluded, re-normalized out of the score) rather than brand opacity. The withdrawn "dose-locked pricing" claim came from a wire release. Sprout publishes "Starting at" prices, which contradicts it — but we did not establish that Sprout fails to publish a titration policy, only that a favourable claim about one was badly sourced.
Last reviewed Sep 14, 2026 · methodology v6View the ledger

Top pick

Sprout Health 5.26/10